Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RenovoRx, Inc. - Common Stock (NQ:RNXT)

1.220 -0.030 (-2.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 134,135
Open 1.275
Bid (Size) 1.220 (11)
Ask (Size) 1.260 (2)
Prev. Close 1.250
Today's Range 1.220 - 1.275
52wk Range 0.7500 - 1.690
Shares Outstanding 36,572,232
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RenovoRx Launches Multi-Center Post-Marketing Registry Study to Evaluate Cancer Treatment Delivered by RenovoCath® Device to Solid Tumors
From RenovoRx, Inc.
Via Business Wire
RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14th at 4:30 p.m. ET
From RenovoRx, Inc.
Via Business Wire

Performance

YTD
-10.3%
-10.3%
1 Month
-7.2%
-7.2%
3 Month
+25.5%
+25.5%
6 Month
-7.2%
-7.2%
1 Year
-4.7%
-4.7%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Earnings Preview For RenovoRx
Via Benzinga
RenovoRx Reports First Quarter 2025 Financial Results and Business Highlights
From RenovoRx, Inc.
Via Business Wire
RenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21st
From RenovoRx, Inc.
Via Business Wire
U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP™) Therapy Platform
From RenovoRx, Inc.
Via Business Wire
Earnings Scheduled For May 15, 2025
Via Benzinga
RenovoRx to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET
From RenovoRx, Inc.
Via Business Wire
Johns Hopkins Medicine Initiates Patient Enrollment for RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial
From RenovoRx, Inc.
Via Business Wire
RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community
From RenovoRx, Inc.
Via Business Wire
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th
From RenovoRx, Inc.
Via Business Wire
RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
From RenovoRx, Inc.
Via Business Wire
RenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual Meeting
From RenovoRx, Inc.
Via Business Wire
RenovoRx Pre-Clinical Results Supporting TAMP™ as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting
From RenovoRx, Inc.
Via Business Wire
RenovoRx CEO to Provide Strategic Update During Fireside Chat on Thursday, April 3rd at 12:00 p.m. ET
From RenovoRx, Inc.
Via Business Wire
RenovoRx Announces Abstract Presentation at the Society of Surgical Oncology (SSO) 2025
From RenovoRx, Inc.
Via Business Wire
RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders
From RenovoRx, Inc.
Via Business Wire
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
From RenovoRx, Inc
Via Business Wire
BioMedNewsBreaks – RenovoRx Inc. (NASDAQ: RNXT) Announces $12.1M Underwritten Public Offering
Via Investor Brand Network
RenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common Stock
From RenovoRx, Inc.
Via Business Wire
What's going on in today's pre-market session
Via Chartmill
RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock
From RenovoRx, Inc.
Via Business Wire

Frequently Asked Questions

Is RenovoRx, Inc. - Common Stock publicly traded?
Yes, RenovoRx, Inc. - Common Stock is publicly traded.
What exchange does RenovoRx, Inc. - Common Stock trade on?
RenovoRx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for RenovoRx, Inc. - Common Stock?
The ticker symbol for RenovoRx, Inc. - Common Stock is RNXT on the Nasdaq Stock Market
What is the current price of RenovoRx, Inc. - Common Stock?
The current price of RenovoRx, Inc. - Common Stock is 1.220
When was RenovoRx, Inc. - Common Stock last traded?
The last trade of RenovoRx, Inc. - Common Stock was at 07/29/25 04:00 PM ET
What is the market capitalization of RenovoRx, Inc. - Common Stock?
The market capitalization of RenovoRx, Inc. - Common Stock is 44.62M
How many shares of RenovoRx, Inc. - Common Stock are outstanding?
RenovoRx, Inc. - Common Stock has 45M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.